Skip to main content
SBC logo

SBC Medical Group Holdings Incorporated (SBC) Stock Price & Analysis

SBC Medical Group Holdings Incorporated (SBC) — MoonshotScore 94/100 (Exceptional band), calculated Nov 18, 2026. Price $5.60 (-10.69%), as of the Nov 19, 2026 trading session; market cap $574M.

Educational signal · not a buy or sell recommendation · How to read this

$5.60 −$0.67 (-10.69%) Market Cap $574M

SBC Medical Group Holdings Incorporated · SBC · NASDAQ

SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers across Japan, Vietnam, and the United States. The company supports franchisees with services ranging from marketing and staff management to clinic construction and IT solutions.

Price as of Nov 19, 2026

Key Statistics

94 of 100

MoonshotScore v2 · SBC Medical Group Holdings (SBC)

Exceptional
Business Quality Elite (97)
Financial Safety Fortress (93)
Valuation Cheap (91)
Growth Durability Fading (36)
Momentum Surging (97)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Elite quality and a fortress balance sheet, at a dirt-cheap price, but weak growth; the market is already moving on it. Business Quality: Elite; Financial Safety: Fortress; Valuation: Cheap; Growth Durability: Fading; Momentum: Surging.

  • quarterly revenue $59M (Q3 FY2026, quarter ended Sep 2026)
  • EPS beat 4 of the last 8 reports
  • Altman Z 4.64 · Piotroski F 6

Helping: business quality, balance-sheet strength, an attractive price, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for SBC (57 recorded, newest six shown)
RecordedScoreBand
92Exceptional
88Exceptional
94Exceptional
94Exceptional
94Exceptional
94Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$5.60
Change on the day-10.69%
52-week range$2.78 – $7.39
Market capitalisation$574M—
Price / earnings (trailing)12.24
Shares traded on the day497.7K

Price & events

Other perspectives

Council score for SBC Medical Group Holdings (SBC): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Strong
Financial Safety Strong
Valuation Strong
Growth Durability Weak
Momentum Strong

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Favorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Favorable read

Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Moderate
Margin of Safety Undervalued
Profit Margin Strong
Revenue Growth Negative
Debt/Equity Moderate
ROE Moderate
Gross Margin Strong

Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 16, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is SBC Medical Group Holdings (SBC), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. SBC Medical Group Holdings Incorporated (SBC) is listed on NASDAQ. It employs 863 people and is led by Yoshiyuki Aikawa. In Q3 FY2026 it reported revenue of $59M and net income of $16M. The market values it at $574M.

2 · Latest results

What do the latest results show for SBC Medical Group Holdings (SBC)?

Short answer · as of

The most recent reported quarter, Q3 FY2026, carried revenue of $59M. Against analyst estimates the company has EPS beat 4 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2026$59M$16M$0.15 (diluted)
Q2 FY2026$49M$11M$0.10 (diluted)
Q1 FY2026$43M$11M$0.11 (diluted)
Q4 FY2025$40M$14M$0.14 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for SBC Medical Group Holdings (SBC)?

Short answer · as of

The MoonshotScore pillars rate business quality, balance-sheet strength, an attractive price, positive momentum as strengths. The distress and quality screens read Altman Z 4.64 · Piotroski F 6. Trailing ratios: ROE 19.4% · ROA 12.2% · current ratio 3.67 · earnings yield 6.9% · free-cash-flow yield 13.1%.

4 · What to check next?

What should you watch next at SBC Medical Group Holdings (SBC)?

Short answer · as of

The stored analyst-target capture is expired, so a current target watchpoint is unavailable.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does SBC Medical Group Holdings compare with its peers?

Short answer

SBC Medical Group Holdings's score ranks 1st of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
SBC Medical Group Holdings (SBC) — this page$5.60$574M94
Exponent, Inc. (EXPO) Same industry, near in market value$89.16 Nov 18, 2026$4.24B90 5-pillar Nov 18, 2026
FTI Consulting, Inc. (FCN) Same industry, near in market value$203.52 Nov 19, 2026$5.55B85 5-pillar Nov 18, 2026
Booz Allen Hamilton Holding Corporation (BAH) Same industry, near in market value$82.65 Nov 19, 2026$9.80B77 5-pillar Nov 18, 2026
Aeries Technology, Inc. (AERT) Same industry, near in market value$4.02 Nov 19, 2026$22.2M77 5-pillar Nov 18, 2026
Huron Consulting Group Inc. (HURN) Same industry, near in market value$166.51 Nov 19, 2026$2.63B76 5-pillar Nov 18, 2026
TransUnion (TRU) Same industry, near in market value$74.47 Nov 19, 2026$14.2B73 5-pillar Nov 18, 2026
Equifax Inc. (EFX) Same industry, near in market value$176.51 Nov 19, 2026$20.7B72 5-pillar Nov 18, 2026
ICF International, Inc. (ICFI) Same industry, near in market value$76.45 Nov 19, 2026$1.37B71 5-pillar Nov 18, 2026
CRA International, Inc. (CRAI) Same industry, near in market value$217.19 Nov 19, 2026$1.36B55 5-pillar Nov 18, 2026
Nordicus Partners Corporation (NORD) Same industry, near in market value$2.85 Nov 18, 2026$56.8M53 5-pillar Nov 18, 2026
ENIGMATIG LTD (EGG) Same industry, near in market value$8.54 Nov 19, 2026$239M46 5-pillar Nov 18, 2026
Forrester Research, Inc. (FORR) Same industry, near in market value$8.76 Nov 19, 2026$159M46 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Last captured analyst target range, low to high (expired, captured Nov 5, 2026)
$9.00 – $15.00
Last captured analyst target (expired, captured Nov 5, 2026)
$12.00
Last captured median analyst target (expired, captured Nov 5, 2026)
$12.00

Historical target record · Captured · Capture expired; not a current watchpoint.

Insider activity

Form 4 records via FMP · Most recent available transactions

Transactions
10
Identified insiders
3
Purchases
0
Sales
3
Other transactions
7

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held SBC in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported SBC in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about SBC Medical Group Holdings (SBC)?

Read these with our analysis →

Common Questions About SBC

These answers are editorial: 1 of these 9 answers is drawn from the SBC research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for SBC?

SBC carries the MoonshotScore stated above — the Exceptional band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers across Japan, Vietnam, and the United States.

Is SBC a good stock to buy?

Stock Expert AI does not rate SBC buy, sell or hold. SBC Medical Group Holdings Incorporated carries a MoonshotScore, in the Exceptional band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the SBC stock price today?

The last price recorded for SBC Medical Group Holdings Incorporated (SBC), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the SBC price target?

The last analyst consensus price target we captured for SBC Medical Group Holdings Incorporated (SBC), with its FMP capture date, is listed under Analyst targets & estimates on this page. That capture has expired, so read it as historical, not as a current target. Targets are analyst opinions, not a Stock Expert AI forecast.

What are the main risks for SBC?

SBC Medical Group Holdings Incorporated faces several risks, including increased competition from larger consulting firms and specialized service providers. Economic downturns could negatively impact consumer spending on cosmetic treatments, affecting SBC's revenue and profitability. Changes in consumer preferences and trends in the cosmetic treatment industry could also pose a challenge.

What are the key factors to evaluate for SBC?

SBC Medical Group Holdings Incorporated (SBC) holds a MoonshotScore in the high range. To weigh it, start with the trailing P/E under Price & valuation on this page. Strategic Partnerships with Medical Equipment Suppliers: Forming strategic alliances with leading medical equipment suppliers can provide SBC's franchisees with access to cutting-edge technologies and preferential pricing. Not financial advice.

How frequently does SBC data refresh on this page?

SBC's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven SBC's recent stock price performance?

SBC Medical Group Holdings Incorporated (SBC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established presence in Japan, Vietnam, and the United States. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider SBC overvalued or undervalued right now?

The trailing P/E of SBC Medical Group Holdings Incorporated (SBC) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 20 figures on this page — 12 from Financial Modeling Prep (FMP), 7 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.